Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing

Abdella, 2005, Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance, Diabet. Med., 22, 278, 10.1111/j.1464-5491.2004.01405.x Bae, 2005, Study on orientation of immunoglobulin G on protein G layer, Biosens. Bioelectron., 21, 103, 10.1016/j.bios.2004.09.003 Boyle, 1987, Bacterial Fc receptors, Biotechnology, 5, 697 Dalimi, 2004, Partially purified fraction (PPF) antigen from adult Fasciola gigantica for the serodiagnosis of human fascioliasis using Dot–ELISA technique, Ann. Saudi Med., 24, 18, 10.5144/0256-4947.2004.18 Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation, N. Engl. J. Med., 340, 448, 10.1056/NEJM199902113400607 Gaede, 2002, Detection of classical swine fever with the LightCycler instrument, Biochemica, 3, 4 Gershov, 2000, C-reactive protein binds to apoptotic cell, protects the cells from the assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity, J. Exp. Med., 192, 1353, 10.1084/jem.192.9.1353 Griselli, 1999, C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction, J. Exp. Med., 190, 1733, 10.1084/jem.190.12.1733 Hokama, 1987, C-reactive protein: current status and future perspectives, J. Clin. Lab. Anal., 1, 15, 10.1002/jcla.1860010104 Homola, 1999, Surface plasmon resonance sensors: review, Sens. Actuators B, 54, 3, 10.1016/S0925-4005(98)00321-9 Khreiss, 2004, Conformational rearrangement in C-reactive protein is required for pro-inflammatory actions on human endothelial cells, Circulation, 109, 2016, 10.1161/01.CIR.0000125527.41598.68 Koenig, 1999, Circulation, 99, 237, 10.1161/01.CIR.99.2.237 Kresl, 1998, Conversion of native oligomeric to a modified monomeric form of human C-reactive protein, Int. J. Biochem. Cell Biol., 30, 1415, 10.1016/S1357-2725(98)00078-8 Ledue, 2001, High sensitivity immunoassays for C-reactive protein: promises and pitfalls, Clin. Chem. Lab. Med., 39, 1171, 10.1515/CCLM.2001.185 Lee, 2003, Fabrication of self-assembled protein A monolayer and its application as an immunosensor, Biosens. Bioelectron., 19, 185, 10.1016/S0956-5663(03)00195-7 Li, 2004, C-reactive is not an only inflammatory marker but also a direct cause of cardiovascular diseases, Med. Hypotheses, 62, 499, 10.1016/j.mehy.2003.12.014 Mortensen, 2001, C-reactive protein, inflammation, and innate immunity, Immunol. Res., 20, 163, 10.1385/IR:24:2:163 Neubert, 2002, Enhanced affinity capture MALDI-TOF MS: orientation of an immunoglobulin G using recombinant protein G, Anal. Chem., 74, 3677, 10.1021/ac025558z Oh, 2004, Fabrication of protein G LB film for immunoglobulin G immobilization, Mater. Sci. Eng. C, 24, 65, 10.1016/j.msec.2003.09.065 Oh, 2005, The fabrication of protein chip based on surface plasmon resonance for detection of pathogens, Biosens. Bioelectron., 20, 1847, 10.1016/j.bios.2004.05.010 Ortega, 2004, Association between C-reactive protein levels and N-terminal Pro-B-Type natriuretic peptide in pre-dialysis patients, Nephron Clin. Pract., 97, c125, 10.1159/000079170 Parchure, 2002, Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of chlamydia pneumoniae infection, Circulation, 105, 1298, 10.1161/hc1102.105649 Pasceri, 2000, Direct pro-inflammatory effect of C-reactive on human endothelial cells, Circulation, 102, 2165, 10.1161/01.CIR.102.18.2165 Pepys, 2003, C-reactive protein: a critical update, J. Clin. Invest., 111, 1805, 10.1172/JCI200318921 Potempa, 1987, Expression, detection and assay of a neoantigen (Neo-CRP) associated with free, human C-reactive protein subunit, Mol. Immunol., 24, 531, 10.1016/0161-5890(87)90028-9 Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N. Engl. J. Med., 336, 973, 10.1056/NEJM199704033361401 Ridker, 1998, Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease, Circulation, 97, 425, 10.1161/01.CIR.97.5.425 Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N. Engl. J. Med., 342, 836, 10.1056/NEJM200003233421202 Ross, 1999, Atherosclerosis: an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Singer, 1957, The latex-fixation test. III. Agglutination test for C-reactive protein and comparison with the capillary precipitin method, Am. J. Clin. Pathol., 28, 611, 10.1093/ajcp/28.6.611 Stenberg, 1991, Quantitative determination of surface concentration of proteins with surface plasmon resonance using radiolabeled protein, J. Colloid Interface Sci., 143, 513, 10.1016/0021-9797(91)90284-F Tanaka, 2000, Fully automated chemiluminescence immunoassay of insulin using antibody–proteinA–bacterial magnetic particle complexes, Anal. Chem., 72, 3518, 10.1021/ac9912505 Verma, 2003, C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation, Am. J. Physiol., 285, R1253 Xia, 1997, Transgenic mice expressing rabbit C-reactive protein (CRP) are resistant to endotoxemia, Proc. Natl. Acad. Sci. U.S.A., 94, 2575, 10.1073/pnas.94.6.2575 Yang, 2005, Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies, J. Nephrol., 18, 102 Yih, 2005, An angular-interrogation attenuated-total-reflection metrology system for plasmonic sensors, Appl. Opt., 44, 6155, 10.1364/AO.44.006155 Ying, 1989, Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies, J. Immunol., 143, 221, 10.4049/jimmunol.143.1.221 Yuk, 2004, Ex situ analysis of protein arrays by SPR spectroscopy for the application of immunosensors, J. Korean Phys. Soc., 44, 967